Figure 1. Prevalence of Cancer Treatment Delays (≥14 Days) or Discontinuations by Race and Ethnicity Among Patients With Cancer Diagnosed With SARS-CoV-2 During the COVID-19 Pandemic, American Society of Clinical Oncology COVID-19 and Cancer Registry Participants.